Treatment of HIV-related primary central nervous system lymphoma with azt high dose, HAART, interleukin-2 and foscarnet in three patients

PURPOSE: Combined immunomodulatory and antiviral treatment was administered to three patients with newly diagnosed HIV-associated primary central nervous system lymphoma (PCNSL) in an attempt to improve outcomes. PATIENTS AND METHODS: Three patients from our institution who were recently diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Marretta, L, Stocker, H, Drauz, D, Mueller, M, Masuhr, A, Dieckmann, S, Wong, V, Koch, A, Grueneisen, A, Arastéh, K, Weiss, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352191/
https://www.ncbi.nlm.nih.gov/pubmed/21719392
http://dx.doi.org/10.1186/2047-783X-16-5-197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352191/
https://www.ncbi.nlm.nih.gov/pubmed/21719392
http://dx.doi.org/10.1186/2047-783X-16-5-197

Ejemplares similares